![John Cornwell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Cornwell
Keine laufenden Positionen mehr
Karriereverlauf von John Cornwell
Ehemalige bekannte Positionen von John Cornwell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sand Hill Angels, Inc.
![]() Sand Hill Angels, Inc. Investment ManagersFinance Sand Hill Angels Inc (Sand Hill Angels) is an angel investment firm founded in 2000. The firm is headquartered in Mountain View, California. | Private Equity Investor | 12.03.2010 | 31.12.2010 |
Corporate Officer/Principal | - | 12.03.2010 | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Cell Genesys, Inc.
![]() Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Corporate Officer/Principal | - | - |
Vaxart, Inc. /Old/
![]() Vaxart, Inc. /Old/ BiotechnologyHealth Technology Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA. | Geschäftsführer | 12.11.2012 | - |
Corporate Officer/Principal | - | 12.11.2012 |
Ausbildung von John Cornwell
University of California, Berkeley | Masters Business Admin |
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Corporate Officer/Principal | 4 |
Masters Business Admin | 2 |
Private Equity Investor | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Sand Hill Angels, Inc.
![]() Sand Hill Angels, Inc. Investment ManagersFinance Sand Hill Angels Inc (Sand Hill Angels) is an angel investment firm founded in 2000. The firm is headquartered in Mountain View, California. | Finance |
Vaxart, Inc. /Old/
![]() Vaxart, Inc. /Old/ BiotechnologyHealth Technology Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Cell Genesys, Inc.
![]() Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- John Cornwell
- Erfahrung